Clinical trial
A Study of Nimotuzumab in Combination With External Radiotherapy in Non-Small…
NCT00369447 · YM BioSciences, Industry · Terminated
Key facts
| NCT number | NCT00369447 |
|---|---|
| Title | A Study of Nimotuzumab in Combination With External Radiotherapy in Non-Small Cell Lung Cancer |
| Official title | A Phase I-II Clinical Study of Nimotuzumab (TheraCIM h-R3) in Combination With External Radiotherapy in Stage IIB, III and IV NSCLC |
| Lead sponsor | YM BioSciences, Industry |
| Collaborators | CIMYM BioSciences |
| Status | Terminated |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Non-small-cell Lung Cancer |
| Intervention type | Biological, Procedure |
| Interventions | External radiotherapy, nimotuzumab |
| Enrollment | 52 |
| Start date | Mar 1, 2009 |
| Primary completion | Jun 1, 2011 |
| Completion | Jul 1, 2011 |
| First posted | Aug 29, 2006 |
| Last update posted | Jul 1, 2011 |
| Countries | Canada, Singapore, United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: